文献速递抗栓抗凝管理特殊人群用药

比伐芦定在成人长期VV-ECMO桥接肺移植中替代肝素的应用:病例系列

Use of bivalirudin after initial heparin management among adult patients on long-term venovenous extracorporeal support as a bridge to lung transplant: A case series.
PubMed 文献 · Pharmacotherapy · 2024-02-02

本病例系列描述6例成人VV-ECMO桥接肺移植患者从普通肝素转换为比伐芦定的结局,中位支持73天。比伐芦定组首次达到治疗性aPTT时间更短,治疗范围时间更长(中位92.9% vs 74.6%),但两种抗凝药使用期间均发生大出血和血栓事件。作者认为比伐芦定是可行选择,需更大样本研究。

要点

  • 比伐芦定较普通肝素更快达到治疗性aPTT,治疗范围时间更长。
  • 转换抗凝药期间仍发生大出血和血栓事件,需密切监测。
  • 桥接肺移植的VV-ECMO患者抗凝最优策略尚需更大研究。

核心结论

  • 基于本病例系列经验,比伐芦定似乎是VV-ECMO桥接肺移植患者抗凝的可行选择。

研究设计与样本

  • 病例系列,纳入6例从普通肝素转换为比伐芦定的成人VV-ECMO桥接肺移植患者。
  • 所有6例患者均以VV-ECMO支持至移植,中位支持时间73天。

主要发现

  • 比伐芦定组首次达到治疗性活化部分凝血活酶时间(aPTT)的时间更短。
  • 比伐芦定组治疗范围时间中位92.9%,普通肝素组中位74.6%。
  • 使用任一种抗凝药期间均发生大出血和血栓事件。

临床怎么用

  • 在VV-ECMO桥接肺移植成人患者中,可考虑比伐芦定作为普通肝素的替代抗凝选择。
  • 转换抗凝药前后需密切监测aPTT及出血、血栓事件。

局限性

  • 样本量仅6例,证据级别有限。
  • 作者指出需要更大规模研究评估桥接移植患者的最佳抗凝策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A growing body of evidence supports the use of bivalirudin as an alternative to unfractionated heparin (UFH) for the prevention of thrombotic events in patients on venovenous (VV) extracorporeal membrane oxygenation (ECMO). However, data in patients bridged to lung transplantation are limited. In this case series, we describe the outcomes of six patients who were transitioned from UFH to bivalirudin during their course of VV ECMO support as a bridge to lung transplantation. All six patients were on VV ECMO support until transplant, with a median duration of 73 days. Bivalirudin demonstrated a shorter time to first therapeutic activated thromboplastin time (aPTT) level. Additionally, time in therapeutic range was longer while patients were receiving bivalirudin compared to UFH (median 92.9% vs. 74.6%). However, major bleeding and thrombotic events occurred while patients were receiving either anticoagulant. Based on our experience, bivalirudin appears to be a viable option for anticoagulation in VV ECMO patients bridged to lung transplantation. Larger studies evaluating the optimal anticoagulation strategy in patients bridged to transplant are needed.

来源:Pharmacotherapy,查看原文。版权归原作者所有。

引用

  1. Halawi H, Harris JE, Goodarzi A, et al. Use of bivalirudin after initial heparin management among adult patients on long-term venovenous extracorporeal support as a bridge to lung transplant: A case series. Pharmacotherapy. 2024. PMID: 38304955. doi:10.1002/phar.2910

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。